Tissue sample acquisition in NSCLC patients
Dr Neal Navani answers the key question: What is the importance of optimal tissue acquisition in lung cancer patients? and gives his recommendations on optimal sample acquisition.
Dr Neal Navani has worked at University College Hospital in London as a Consultant in Thoracic Medicine since 2011 and is Lead Clinician for Lung Cancer. He is an Associate Professor at UCL. He is also a member of the National Cancer Research Institute lung cancer clinical studies group and lung cancer pathway director for London Cancer.
NSCLC, Non-Small Cell Lung Cancer; NICE, The National Institute for Health and Care Excellence
PP-XLK-GBR-1153 April 2020